Prosecution Insights
Last updated: May 29, 2026

Lenz Therapeutics Operations Inc.

5 pending office actions • 3 art units • 3 examiners • 0 of 5 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Portfolio Summary

5
Total Pending OAs
4
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 5 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 5 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
1
Medium (20%)
1
Easy (20%)
3
Unknown (60%)

Rejection Statute Mix

BucketCases
§103 only1 (20%)
§112 only1 (20%)
No statute on record3 (60%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
40% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
3
Business / Other
60% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

50 h
Manual time on pending OAs
10 h
Time saved (low, 20%)
18 h
Time saved (mid, 35%)
0.4 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DIAMOND, ALAN D 3 71.2% +8.2%
WRIGHT, SARAH C 1 41.5% +46.9%
WILSON, JERICA KATLYNN 1 60.6% +40.0%

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18301361 METHODS FOR THE TREATMENT OF PRESBYOPIA WILSON, JERICA KATLYNN 49d overdue
18241733 COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA WRIGHT, SARAH C 15d overdue

Top Art Units

Art UnitApps
3991 3
1619 1
1621 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18766429 COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA DIAMOND, ALAN D 3991 Other Non-Final OA 5d overdue Pending Jul 08, 2024
18765066 COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA DIAMOND, ALAN D 3991 §112 Non-Final OA 5d overdue Pending Jul 05, 2024
18765156 CONTACT LENS COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA DIAMOND, ALAN D 3991 Other Non-Final OA 5d overdue Pending Jul 05, 2024
18241733 COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA WRIGHT, SARAH C 1619 Other Final Rejection 15d overdue Pending Sep 01, 2023
18301361 METHODS FOR THE TREATMENT OF PRESBYOPIA WILSON, JERICA KATLYNN 1621 §103 Non-Final OA 49d overdue Pending Apr 17, 2023

Managing Lenz Therapeutics Operations Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month